News
U.S. telehealth upstart Hims & Hers Health, Inc. is planning to enter the Canadian market with an eye to selling generic ...
WHEN you invest in yourself, you want to see results quickly. And one woman who is spending hundreds on mounjaro every month ...
The weight-loss drug boom has dominated headlines for the last two years — but underneath the hype lies a major flaw in the ...
Gemma Collins says she was shocked by how her face changed after losing two stone on Mounjaro. Experts warn of a side effect ...
Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?
A 49-year-old Bangor woman was today sentenced for multiple breaches of the Human Medicines Regulations and Fraud Act.
For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...
Hims and Hers Health is planning to cash in on Novo Nordisk losing its semaglutide drug exclusivity in Canada. The telehealth ...
A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a ...
U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results